Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 2
1942 6
1943 9
1944 7
1945 24
1946 82
1947 56
1948 54
1949 36
1950 33
1951 19
1952 22
1953 30
1954 31
1955 30
1956 11
1957 6
1958 6
1959 8
1960 9
1961 6
1962 7
1963 48
1964 70
1965 44
1966 43
1967 59
1968 67
1969 65
1970 86
1971 96
1972 77
1973 94
1974 105
1975 71
1976 63
1977 60
1978 59
1979 99
1980 85
1981 80
1982 84
1983 54
1984 64
1985 67
1986 51
1987 68
1988 70
1989 80
1990 82
1991 75
1992 98
1993 85
1994 71
1995 80
1996 84
1997 74
1998 67
1999 80
2000 70
2001 66
2002 76
2003 78
2004 93
2005 93
2006 99
2007 102
2008 100
2009 123
2010 148
2011 112
2012 159
2013 158
2014 149
2015 151
2016 181
2017 175
2018 218
2019 256
2020 265
2021 272
2022 267
2023 267
2024 98

Text availability

Article attribute

Article type

Publication date

Search Results

6,486 results

Results by year

Filters applied: . Clear all
Page 1
Standard Selection Treatments with Sulfadiazine Limit Plasmodium yoelii Host-to-Vector Transmission.
Rios KT, Dickson TM, Lindner SE. Rios KT, et al. mSphere. 2022 Jun 29;7(3):e0010622. doi: 10.1128/msphere.00106-22. Epub 2022 May 19. mSphere. 2022. PMID: 35586987 Free PMC article.
To determine if there was a significant effect of sulfadiazine exposure upon transmission, we transmitted Plasmodium yoelii (17XNL strain) parasites to Anopheles stephensi mosquitoes and evaluated the prevalence and intensity of infection under different sulfadiazine …
To determine if there was a significant effect of sulfadiazine exposure upon transmission, we transmitted Plasmodium yoelii (17XNL st …
Toxoplasmosis in AIDS patients.
Tuazon CU. Tuazon CU. J Antimicrob Chemother. 1989 Jan;23 Suppl A:77-82. doi: 10.1093/jac/23.suppl_a.77. J Antimicrob Chemother. 1989. PMID: 2654118 Review.
Diagnosis is made on the basis of clinical presentation and CAT scan findings and confirmed by demonstration of tachyzoites and/or cysts in tissues obtained by needle aspiration or brain biopsy. Response to therapy with pyrimethamine and sulphadiazine is usually prompt but …
Diagnosis is made on the basis of clinical presentation and CAT scan findings and confirmed by demonstration of tachyzoites and/or cysts in …
Sulfadiazine revisited.
Ventura MG, Wybran J, Farber CM. Ventura MG, et al. J Infect Dis. 1989 Sep;160(3):556-7. doi: 10.1093/infdis/160.3.556. J Infect Dis. 1989. PMID: 2760508 No abstract available.
Silver sulfadiazine: an antibacterial agent for topical use in burns. A review of the literature.
Hoffmann S. Hoffmann S. Scand J Plast Reconstr Surg. 1984;18(1):119-26. doi: 10.3109/02844318409057413. Scand J Plast Reconstr Surg. 1984. PMID: 6377481 Review.
Topical antibacterial treatment is of major importance in the burn patient. Silver sulfadiazine is an effective agent with low toxicity and few side effects. ...Silver sulfadiazine may be used in a variety of other conditions than burns....
Topical antibacterial treatment is of major importance in the burn patient. Silver sulfadiazine is an effective agent with low toxici …
Evaluation of the effect of guanabenz-loaded nanoparticles on chronic toxoplasmosis in mice.
Abdelhamid Elgendy WM, Haggag YA, El-Nouby KA, El-Kowrany SI, El Marhoumy SM. Abdelhamid Elgendy WM, et al. Exp Parasitol. 2023 Mar;246:108460. doi: 10.1016/j.exppara.2023.108460. Epub 2023 Jan 13. Exp Parasitol. 2023. PMID: 36642299
Treated mice received either guanabenz alone (5 mg/kg/day) in subgroup IIa or guanabenz-loaded nanoparticles by full dose in subgroup IIb or guanabenz-loaded nanoparticles by the half dose (2.5 mg/kg/day) in subgroup IIc. Subgroup Ie was treated by pyrimethamine and sulfadiazi …
Treated mice received either guanabenz alone (5 mg/kg/day) in subgroup IIa or guanabenz-loaded nanoparticles by full dose in subgroup IIb or …
Clinical pharmacokinetics of co-trimazine.
Bergan T, Ortengren B, Westerlund D. Bergan T, et al. Clin Pharmacokinet. 1986 Sep-Oct;11(5):372-86. doi: 10.2165/00003088-198611050-00003. Clin Pharmacokinet. 1986. PMID: 3536256 Review.
The clinical pharmacokinetics of co-trimazine (trimethoprim plus sulphadiazine) are reviewed and compared with those of co-trimoxazole (trimethoprim plus sulphamethoxazole). ...This measure shows a penetration into peripheral human lymph of 68% for sulphadiazine and …
The clinical pharmacokinetics of co-trimazine (trimethoprim plus sulphadiazine) are reviewed and compared with those of co-trimoxazol …
Landmark perspective: Sulfadiazine.
Petersdorf RG. Petersdorf RG. JAMA. 1984 Mar 16;251(11):1475-6. doi: 10.1001/jama.251.11.1475. JAMA. 1984. PMID: 6366264 No abstract available.
Malnutrition and drugs: clinical implications.
Mehta S. Mehta S. Dev Pharmacol Ther. 1990;15(3-4):159-65. doi: 10.1159/000457640. Dev Pharmacol Ther. 1990. PMID: 2129200 Review.
Elimination kinetics determined by a timed plasma concentration curve on chloramphenicol, antipyrine, acetaminophen and sulphadiazine showed that plasma half-life was increased and elimination rate constant was diminished in malnourished children compared to those with nor …
Elimination kinetics determined by a timed plasma concentration curve on chloramphenicol, antipyrine, acetaminophen and sulphadiazine …
Crystalluria with sulphadiazine.
Smith JM, Curi AL, Pavesio CE. Smith JM, et al. Br J Ophthalmol. 2001 Oct;85(10):1265. doi: 10.1136/bjo.85.10.1260e. Br J Ophthalmol. 2001. PMID: 11596582 Free PMC article. No abstract available.
6,486 results